HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (1- (2- (2,3- dihydro- 1- benzofuran- 5- yl)ethyl)piperidin- 3- yl)- 2,2- diphenylacetamide

UK-201844 is the (3R)-isomer; an anti-HIV agent; structure in first source

Also Known As:

UK 201844; UK-201844; UK201844

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - 2-(1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)piperidin-3-yl)-2,2-diphenylacetamide: 1
Organic Chemicals: 133
- Amides: 2428
  - Acetamides: 21
    - Benzeneacetamides
      - 2-(1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)piperidin-3-yl)-2,2-diphenylacetamide: 1
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzeneacetamides
        2-(1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)piperidin-3-yl)-2,2-diphenylacetamide: 1

Experts

1.	Blair, Wade S: 1 article (10/2007)
2.	Butler, Scott L: 1 article (10/2007)
3.	Cao, Joan: 1 article (10/2007)
4.	Chu, Alex: 1 article (10/2007)
5.	Graham, Joanne: 1 article (10/2007)
6.	Isaacson, Jason: 1 article (10/2007)
7.	Jackson, Lynn: 1 article (10/2007)
8.	Jimenez, Judith: 1 article (10/2007)
9.	Malfait, Anne-Marie: 1 article (10/2007)
10.	Patick, Amy K: 1 article (10/2007)

Related Diseases

1.	Vesicular Stomatitis 10/01/2007 - "UK-201844 specifically inhibited the production of infectious virions packaged with an HIV-1 envelope (Env), but not HIV virions packaged with a heterologous Env (i.e., the vesicular stomatitis virus glycoprotein), suggesting that the compound targets HIV-1 Env late in infection. "
2.	Infections 10/01/2007 - "UK-201844 specifically inhibited the production of infectious virions packaged with an HIV-1 envelope (Env), but not HIV virions packaged with a heterologous Env (i.e., the vesicular stomatitis virus glycoprotein), suggesting that the compound targets HIV-1 Env late in infection. "

Related Drugs and Biologics

1.	Glycoproteins (Glycoprotein)